InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Marks Lilly, 董事. Director active across 1 company, notably Orthofix Medical Inc.. Aggregated, 2 reports have been logged. History available since 21 June 2021. The latest transaction was disclosed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Marks Lilly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
6,383 股0Common StockSEC:0001209191-22-035037:0
4,313 股0Common StockSEC:0001209191-21-042747:0
2 条申报中的 2 条
About Marks Lilly
Lilly Marks is a Director of Orthofix Medical Inc. As a board member, she participates in overseeing the company's activities and making strategic decisions. Her experience and skills in corporate governance are essential for guiding Orthofix Medical Inc. in its growth and innovation objectives.
